Max Robotics — Global Service Robot Directory + US Certification

About

Claudia Sangalli is a pioneering breast surgeon whose work is redefining the landscape of oncologic surgery through the integration of robotics. Her primary research focuses on the feasibility, safety, and patient outcomes of robotic mastectomy, particularly for women with breast cancer or BRCA mutations. Dr. Sangalli’s landmark 2021 randomized trial, comparing robotic mastectomy to open surgery, demonstrated that the robotic approach offers comparable oncologic safety with superior cosmetic results and reduced morbidity—a finding that has garnered over 100 citations and reshaped clinical protocols. Her comprehensive 2019 update on robotic breast surgery, with 88 citations, remains a foundational review for surgeons adopting this technology. More recently, her 2023 work has positioned robot-assisted mastectomy as the next major advance in the field. With a career dedicated to minimally invasive innovation, Dr. Sangalli has not only advanced surgical technique but also improved quality of life for countless patients. Her contributions are essential reading for any researcher or clinician interested in the future of breast cancer surgery.